CTOR
CITIUS ONCOLOGY, INC.
+0.05 (+4.82%)1.00USD93.3K成交股數93.0M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 9 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.5M | 1.7M | 3.9M | – | – | – | – | – | – | – | – | – |
| 營業成本 | 492K | 329K | 789K | – | – | – | – | – | – | – | – | – |
| 毛利 | 1.0M | 1.3M | 3.2M | – | – | – | – | – | – | – | – | – |
| 毛利率 | 67.1% | 80.3% | 80.0% | – | – | – | – | – | – | – | – | – |
| 研發費用 | 218K | 1.1M | 1.0M | 1.1M | 938K | 3.1M | 1.3M | 1.1M | 1.3M | 1.1M | – | – |
| 銷售管理費用 | 4.2M | 23.6M | 2.9M | 1.3M | 1.9M | 2.2M | 3.3M | 1.5M | 1.4M | 1.5M | 421K | 200K |
| 營業利益 | −8.7M+76% | −28.6M+283% | −5.3M-18% | −4.7M+2% | −4.9M+1742% | −7.5M | −6.4M+1417% | −4.6M+2220% | −268K | – | −421K | −200K |
| 營業利益率 | -583.5% | -1,716.2% | -133.2% | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −8.9M+66% | −26.6M+244% | −5.5M-17% | −5.0M+5% | −5.4M+11% | −7.7M+64% | −6.7M-4316% | −4.8M-874% | −4.8M | −4.7M | 158K | 616K |
| 淨利率 | -597.4% | -1,596.0% | -140.3% | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.080% | -0.27+145% | -0.06-33% | -0.06-14% | -0.08+14% | -0.11+57% | -0.09-550% | -0.07-200% | -0.07 | -0.07 | 0.02 | 0.07 |
| 稀釋股數 | 108M | 100M | 87.5M | 73.3M | 71.6M | 71.6M | 71.6M | 67.5M | 67.5M | 67.5M | 6.6M | 6.6M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 16.6M | 2.6M | 7.3M | 3.9M | 112.00 | 112.00 | 112.00 | – | – | – | – | – |
| 應收帳款 | 686K | 1.1M | 4.0M | – | – | – | – | – | – | – | – | – |
| 存貨 | 22.6M | 22.7M | 22.6M | 22.3M | 17.2M | 15.3M | 14.4M | – | – | – | – | – |
| 總資產 | 112M | 101M | 110M | 101M | 91.7M | 91.4M | 90.5M | 49.2M | 48.7M | 72.6M | 47.7M | 69.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 71.7M | 65.4M | 51.6M | 56.1M | 59.3M | 55.8M | 49.2M | – | – | – | 22.2M | – |
| 股東權益 | 40.4M | 35.3M | 58.4M | 44.9M | 32.4M | 35.6M | 41.3M | 17.0M | 19.8M | 22.7M | 25.5M | −2K |
| 負債比 | 64.0% | 65.0% | 46.9% | 55.6% | 64.7% | 61.0% | 54.4% | – | – | – | 46.5% | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −7.4M | – | – | – | – | – | −192K | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −24.8M | –% | -0.34 | – |
| FY2024 | – | – | −21.1M | –% | -0.31 | – |
| FY2024 | – | – | 2.4M | –% | 0.27 | – |
| FY2023 | – | – | −12.7M | –% | -0.19 | – |
| FY2023 | – | – | 381K | –% | 0.12 | – |